The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in ...

The new program will reduce prices on these products by 40% on average, and there are greater savings possible on select medications, according to an announcement. The list of drugs covers a slew ...

Oct 31 (Reuters) - A group of insurers suing Walgreens (WBA.O), opens new tab over its drug-price reimbursements must pay the retail pharmacy giant's legal fees stemming from a pretrial dispute in the ...